BACKGROUND, In numerous studies tumor thickness has been shown to be t
he most important prognostic factor for patients with localized cutane
ous melanoma. However, to our knowledge there are no population-based
studies analyzing the prognosis of patients living in the United State
s with cutaneous melanoma. METHODS, A prognostic model was developed w
ith death as an outcome for 548 patients from Connecticut with localiz
ed cutaneous melanoma Only patients with invasive melanoma who either
died of the disease or were followed-up at least five years were studi
ed. Fourteen pathologic parameters (histologic type of melanoma, Clark
level, microscopic satellites, histologic regression, tumor thickness
[Breslow], ulceration, vascular invasion, mitotic rate per mm(2), tum
or-infiltrating lymphocytes, radial vs. vertical growth phase, solar e
lastosis, co-existing nevus, lymphocytic response, and pigmentation) a
nd three clinical variables (age, sex, and anatomic site) were analyze
d using logistic regression. RESULTS. After univariate analysis, 10 pa
thologic variables showed prognostic significance: histologic type (no
dular and ''other'' types only), Clark level, microscopic satellites,
regression (protective), tumor thickness, ulceration, vascular invasio
n, mitotic rate, vertical growth phase, and solar elastosis (protectiv
e). In the final model employing multivariate analysis, only tumor thi
ckness and mitotic rate continued to have independent predictive value
. CONCLUSIONS. In this population-based study of 548 patients in Conne
cticut, tumor thickness was the most significant prognostic factor for
survival of patients with localized cutaneous melanoma. Other prognos
tic factors studied to date have not been conclusively verified as pro
viding any additional information beyond that of tumor thickness. (C)
1996 American Cancer Society.